Skip to main content

Table 1 Average sCD26 concentration for the groups studied according to the colonoscopy result.

From: Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas

No colorectal

pathology

Clinical condition

n

Mean ±

SD sCD26 (ng/mL)

 

Rectal bleeding

8

651.5 ± 190.2

 
 

Abdominal pain

10

586.1 ± 194.4

 
 

Diarrhoea

9

649.5 ± 306.8

641.2 ± 241.2

 

Anaemia

7

370.8 ± 144.7

 
 

Constipation

4

782.7 ± 194.6

 
 

No symptoms*

30

698.5 ± 234.2

 

Colorectal

pathology

Diagnosis

n

Mean ± SD

sCD26 (ng/mL)

Non-inflammatory bowel disease

Haemorrhoids

36

655.3 ± 240.4

612.2 ± 231.0

(non-IBD)

Diverticula

28

556.7 ± 209.6

 

Inflammatory bowel disease

Colitis

20

413.2 ± 195.5

434.4 ± 239.7

(IBD)

Crohn's disease

6

505.1 ± 355.8

 
 

Hyperplastic polyps

18

560.4 ± 201.3

 

Polyps

Non-advanced adenomas

40

611.1 ± 263.8

588.0 ± 246.5

 

Advanced adenomas

48

566.7 ± 225.8

 

CRC

Duke's A

2

513.9 ± 240.4

 
 

Duke's B

12

369.8 ± 147.4

403.7 ± 278.2

 

Duke's C

15

402.0 ± 360.3

 
 

Duke's D

4

457.0 ± 323.0

 
  1. SD: standard deviation of the mean; *: personal history of polyps or CRC, or familial history of CRC.